Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CorMedix Inc. Director's Dealing 2010

Aug 18, 2010

32333_dirs_2010-08-18_48a3fadd-f057-45af-859b-247b63462fb3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2010-08-16

Reporting Person: LENZ BRIAN (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-08-16 Common Stock, $0.001 par value per share P 1000 $1.5400 Acquired 3000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-08-16 Warrants issued as a part of Units $3.4375 P 100 Acquired 2015-03-24 Common Stock, $0.001 par value per share (100) Direct
2010-08-16 Warrants issued as a part of Units $3.4375 P 100 Acquired 2015-03-24 Common Stock, $0.001 par value per share (100) Direct
2010-08-16 Warrants issued as a part of Units $3.4375 P 800 Acquired 2015-03-24 Common Stock, $0.001 par value per share (800) Direct

Footnotes

F1: These warrants are exercisable.